Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance

QR Code

Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance

The liver executes versatile functions and is the chief organ for metabolism of toxicants/xenobiotics. Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and the third foremost cause of cancer death worldwide. Oxidative stress is a key factor related with the development and...

Full description

Bibliographic Details
Main Authors:	Raghunath, A., Sundarraj, K., Arfuso, Frank, Sethi, G., Perumal, E.
Format:	Journal Article
Published:	MDPI AG 2018
Online Access:	http://hdl.handle.net/20.500.11937/74689

Similar Items

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
by: Swamy, S., et al.
Published: (2016)

NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
by: Monisha, J., et al.
Published: (2018)

Hepatocellular Carcinoma
by: Tirnitz-Parker, Janine
Published: (2019)

Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)

Interplay of autophagy and cancer stem cells in hepatocellular carcinoma
by: Wong, M. M. T., et al.
Published: (2021)

Selenium and hepatocellular carcinoma
by: Nasar Alwahaibi,, et al.
Published: (2008)

Liver progenitor cells, cancer stem cells and hepatocellular carcinoma
by: Tirnitz-Parker, Nina, et al.
Published: (2012)

Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression
by: Zoheir, Khairy MA, et al.
Published: (2015)

Mouse Models of Hepatocellular Carcinoma
by: Carlessi, Rodrigo, et al.
Published: (2019)

Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
by: Ip, Carman K.M., et al.
Published: (2016)

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
by: Subramaniam, A., et al.
Published: (2012)

The role of Nrf2 in oxidative stress-induced endothelial injuries
by: Chen, B., et al.
Published: (2015)

Antioxidant response elements: Discovery, classes, regulation and potential applications
by: Raghunath, A., et al.
Published: (2018)

ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
by: Begicevic, R., et al.
Published: (2017)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)

Screening for hepatocellular carcinoma: patient selection and perspectives
by: Fateen, Waleed, et al.
Published: (2017)

Hepatocellular carcinoma with disseminated skeletal muscle metastasis
by: Abdul Rahim, Ezamin, et al.
Published: (2017)

HBV-related hepatocellular carcinoma: The role of integration, viral proteins and miRNA
by: Lim, L., et al.
Published: (2012)

Evidence for the Involvement of the Master Transcription Factor NF-?B in Cancer Initiation and Progression.
by: Puar, Y., et al.
Published: (2018)

Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
by: Manu, K., et al.
Published: (2013)

Characterisation of tumorspheres generated from nasopharyngeal carcinoma cell line TW06 and chemoresistance to docetaxel
by: Goh, Iris Wen Li, et al.
Published: (2015)

Immune checkpoint inhibition: Prospects for prevention and therapy of hepatocellular carcinoma
by: Elsegood, Caryn, et al.
Published: (2017)

Dynamics of the oncofetal ecosystem during Hepatocellular carcinoma evolution
by: Pai, Rhea Girish
Published: (2024)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen, Waleed, et al.
Published: (2017)

Wnt Signaling Pathway Related Genes In Hepatocellular Carcinoma
by: Ban, Kechen
Published: (2002)

Characterization of tumorspheres generated from nasopharyngeal carcinoma cell line, TW06 and chemoresistance to docetaxel and oxaliplatin
by: Goh, Iris Wen Li, et al.
Published: (2015)

Exploring the role of multidrug exporters and extracellular vesicles in medulloblastoma chemoresistance
by: Wade, Philippa
Published: (2024)

Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
by: Obaid Al-Qubaisi, Mothanna Sadiq
Published: (2009)

Characterization and chemoresistance of HT29 (Colon cancer) and TW06 (Nasopharyngeal cancer) tumorspheres
by: Goh, Iris Wen Li
Published: (2014)

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)

Development and validation of an autoantibody-based blood test for hepatocellular carcinoma
by: Welberry, Christopher J.
Published: (2019)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway
by: Pandurangan, Ashok Kumar, et al.
Published: (2015)

A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2017)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinoma
by: Chia, Chok Seng, et al.
Published: (2002)

GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
by: Ban, Ke Chen, et al.
Published: (2003)

Cannot write session to /tmp/vufind_sessions/sess_dvjv1aa3rrijco5l5i1ra9otcc